Trial intelligence / Profile preview

Continuous outpatient terlipressin infusion for refractory ascites

ACTRN12616000321448Phase 2Completed

Sponsor
Paul Gow
Start
Jul 2015
Modality
Peptides
Countries
1
01

Overview

Phase 2 trial of terlipressin, sponsored by Paul Gow. Started Jul 2015; status: completed.

02

Drugs

terlipressin

Beyond the preview

Go deeper on ACTRN12616000321448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000321448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call